Related content

Daunorubicin Metabolism in Leukemic Cells Isolated from Patients with Acute Myeloid Leukemia

By  

Drug Metabolism Letters, Vol. 4, Iss. 4, 2010-12 ,pp. : 228-232

Bentham Science Publishers

Access to resources Recommend Favorite

Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression

By Shi Pengcheng   Zha Jie   Guo Xutao   Chen Feili   Fan Zhiping   Huang Fen   Meng Fanyi   Liu Xiaoli   Feng Ru   Xu Bing  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 17-23

Future Medicine

Access to resources Recommend Favorite

A case-control study of the effects of hydroxyurea on circulating cortisol levels in patients with acute myelogenous leukemia and chronic myeloproliferative disorders

By Navarra P.   Aloe-Spiriti M.A.   Boccarini F.   Montefusco E.   Latagliata R.   Preziosi P.   Petti M.C.  

Pharmacological Research, Vol. 42, Iss. 4, 2000-10 ,pp. : 389-392

Academic Press

Access to resources Recommend Favorite

The clinically relevant pharmacogenomic changes in acute myelogenous leukemia

By Emadi Ashkan   Karp Judith E  

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1257-1269

Future Medicine

Access to resources Recommend Favorite

How to Monitor Patients with Chronic Myelogenous Leukemia

By O'Dwyer Michael E  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 1, Iss. 4, 2003-11 ,pp. : 513-517

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite